View Document Preview and Link Document Date: 2015-05-29 16:01:42 Open Document File Size: 880,12 KB Share Result on Facebook
City York / New Orleans / Houston / Nashville / Lexington / / Company AEs / 5Curis Inc. / Grade 3 AE / Reduction Introduction 5Curis Inc. / / Event FDA Phase / / Facility Memorial MemorialSloan-Kettering Sloan-KetteringCancer CancerCenter / NY;22Sarah SarahCannon CannonCancer Cancer Institute / / IndustryTerm cancer signaling networks / treatment of cutaneous T-cell lymphoma / / MedicalCondition tumor / cutaneous T-cell lymphoma / cancer / implanted cancer / lymphoma / Multiple Myeloma / refractory lymphoma / disease / B Cell Lymphoma / neutropenia lasting / hematological malignancies / metastasis / Malignant Lymphoma / mouse tumor / neutropenia / thrombocytopenia / peripheral T-cell lymphoma / fatigue / Progressive disease Subject/Physician decision Treatment-related toxicity / human B-cell tumor / Hodgkin’s Lymphoma / Hodgkin’s lymphoma / diffuse large B-cell lymphoma / stable disease / diarrhea / infection / MS / evaluable disease / acute myeloid leukemia / Relapsed Lymphoma / Fatigue Nausea Neutropenia/decr / / MedicalTreatment Bone Marrow Transplant / / Organization ANC ALP / Leukemia & Lymphoma Society / U.S. Food and Drug Administration / NY;22Sarah SarahCannon CannonCancer Cancer Institute / Drug Administration / / Person Berdeja / Voi / Yasuhiro YasuhiroOki / Cheng-Jung Lai / Robert Robert Laliberte / Ian IanW / Maurizio MaurizioVoi / Amanda Amanda Copeland / Ali Fattaey / Younes / Multiple Myeloma Anas Lai / / Position Progressive disease Subject/Physician / / Product H3 / of / / ProvinceOrState Texas / Tennessee / New York / Massachusetts / / Technology alpha / pharmacokinetics / gene expression / apoptosis / / SocialTag 
Curis Poster-Front+Back Covers.indd